Summary Intellect Neurosciences Inc (Intellect Neuro) is a biotechnology company that discovers and develops therapeutic products for the treatment and prevention of Alzheimer's disease and other serious neurological disorders. The company’s internal drug discovery programs offers therapeutic applications for monoclonal antibodies and antibody-drug conjugates. Its pipeline products include SHP622, which is used for the treatment of Friedreich’s Ataxia. Intellect Neuro has in-licensed a mono...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.